EUVIMEDEUVIMED entdecken
Crossref

The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A

Jinchang Lu, Yang Shao, Sanjay Saw, Hui Fang, Guohui Song, Yan Chen, Qinglian Tang, Geoffrey Wood, Jin Wang, Paul Waterhouse, Jingnan Shen, Rama Khokha

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.218045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Jinchang Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, PR China; Princess Margaret Cancer Centr…. Hauptthemen laut MEDLINE: Histone-Lysine N-Methyltransferase, Osteosarcoma, Bone Neoplasms, Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Canadian Cancer Society, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcomas (OS) have highly chaotic genomes, yet their cancer drivers are poorly defined. Leveraging cross-species OS genomics we identify the frequent amplification of NSD3, a histone lysine methyltransferase and expose the NSD3-ARID3A axis as a core pathway in osteosarcomagenesis. Loss- and gain-of-function studies with CRISPR-Cas9 and lentivirus systems establish the causal role of NSD3 in OS tumor growth and spontaneous metastasis. NSD3 specifically enhances H3K27 di-methylation to initiate oncogenic reprogramming and inactivates the transcriptional repressor ARID3A. This culminates in altered expression of instructive genes RUNX2, MMP13, OCT4 and NANOG generating a shift in osteosarcoma cell differentiation to a primitive state. In human OS, NSD3 overexpression is seen in patient tumors and predicts a poor clinical outcome. Our study uncovers the crucial epigenetic dysregulation of histone lysine methyltransferase in osteosarcoma, opening new possibilities for therapy with epigenetic drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone-Lysine N-MethyltransferaseOsteosarcomaBone NeoplasmsTranscription FactorsDNA-Binding ProteinsNuclear ProteinsHumansAnimalsGene Expression Regulation, NeoplasticCell Line, TumorHistonesEpigenesis, GeneticCell DifferentiationMice

Substanzen

Histone-Lysine N-MethyltransferaseTranscription FactorsDNA-Binding ProteinsNuclear ProteinsNSD3 protein, humanHistones

Autor:innen und Institutionen

  • Department of Orthopedic Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, PR China; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada; Depar…
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.
  • Department of Orthopedic Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, PR China; Department of Musculoskeletal Oncology, State Key Laboratory of Oncology in South China, Guangdong P…
  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.
  • Department of Orthopedic Oncology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, PR China. Electronic address: shenjn@mail.sysu.edu.cn.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada. Electronic address: rama.khokha@uhn.ca.

Förderung

  • National Natural Science Foundation of China
  • Canadian Cancer Society
  • Canadian Institutes of Health Research

Zitieren

APA

Lu, J., Shao, Y., Saw, S., Fang, H., Song, G., Chen, Y., Tang, Q., Wood, G., Wang, J., Waterhouse, P., Shen, J., & Khokha, R. (2025). The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218045

Vancouver

Lu J, Shao Y, Saw S, Fang H, Song G, Chen Y, et al. The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.218045

BibTeX
@article{Lu2025,
  author = {Lu, Jinchang and Shao, Yang and Saw, Sanjay and Fang, Hui and Song, Guohui and Chen, Yan and Tang, Qinglian and Wood, Geoffrey and Wang, Jin and Waterhouse, Paul and Shen, Jingnan and Khokha, Rama},
  title = {The histone lysine methyltransferase NSD3 drives osteosarcomagenesis by inactivating ARID3A},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.218045}
}
Kostenlos starten →